Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NCR Voyix Reports Preliminary Revenue of 963 Million for Q4 2023 Just Under Projection

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Technology Blockchain Markets and money
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

As of February 29, 2024, NCR Voyix reported a preliminary revenue of $963 million for the fourth quarter of 2023. This figure was just under the projected amount of $963.98 million.

VYX Stock Update: February 29, 2024 – Positive Momentum in Regular Trading Hours, After-Hours Drop Reminder of Market Volatility

On February 29, 2024, VYX stock closed at $14.61, marking a $0.30 increase from the previous market close, representing a 2.10% rise. However, the after-hours trading session saw a slight drop in the stock price, with VYX shedding $0.61. The stock was trading in the middle of its 52-week range and below its 200-day simple moving average. Investors should consider broader market conditions and conduct thorough research before making any investment decisions. Overall, the performance of VYX on February 29, 2024, showcased some positive momentum during regular trading hours, but the drop in after-hours trading serves as a reminder of the unpredictable nature of the stock market.

VYX Stock Performance Review: Mixed Results on February 29, 2024

On February 29, 2024, VYX stock experienced mixed performances based on the financial data provided. The total revenue for the company was reported at $7.84 billion for the past year, showing a 9.61% increase compared to the previous year. However, the total revenue remained flat at $2.02 billion for the third quarter.

The net income for VYX was $60.00 million for the past year, but it took a significant hit in the third quarter, dropping to -$124.00 million. This represents a 38.14% decrease in net income since the previous year and a staggering 720.0% decrease since the last quarter.

Earnings per share (EPS) also saw a decline for VYX stock. The EPS was reported at $0.31 for the past year, but plummeted to -$0.91 for the third quarter. This marks a 46.52% decrease in EPS since the previous year and a staggering 959.41% decrease since the last quarter.

Overall, the financial performance of VYX stock on February 29, 2024, was a mixed bag. Investors will need to closely monitor the company’s financial health and performance indicators to make informed decisions about their investment in VYX stock.

Tags: VYX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
EEFT stock news

Analyzing CPSIs Q4 Earnings Report A Detailed Review

Fitness and app

Title Xponential Fitness Q4 Earnings Report Insights for Investors

Finance_Capitalization

Analyzing Organogenesis Holdings Incs Q4 Earnings Performance

Recommended

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

2 years ago
CryoLife Stock

Medical Device Specialist Artivion Maintains Strong Analyst Backing

3 months ago
Walgreens Boots Alliance Stock

Walgreens Concludes Public Trading Era Following Landmark Acquisition

3 months ago
MA stock news

Analysis of Short Interest and Financial Performance of US Bancorp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

by Felix Baarz
January 11, 2026
0

Eli Lilly and Company has opened 2026 with a clear strategic push to diversify and strengthen its...

Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Viking Therapeutics Stock

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

January 11, 2026
Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances
  • Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs
  • Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com